NCT04068610 2026-05-15COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRCMedImmune LLCPhase 1/2 Active not recruiting61 enrolled 35 charts